Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity

Moran Saar Ray, Oren Moskovich, Ohad Iosefson, Zvi Fishelson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Background: Mortalin was shown to contribute to removal of the complement membranolytic C5b-9 complex from the target cell surface. Results: Modulations of mortalin expression and activity affect deposition of C5b-9 and cell death. Conclusion: Mortalin, through its ATPase domain, regulates the C5b-9 deposition and confers resistance to complement-dependent cytotoxicity. Significance: Mortalin is a potential therapeutic target in autoimmune diseases and in cancer immunotherapy.

Original languageEnglish
Pages (from-to)15014-15022
Number of pages9
JournalJournal of Biological Chemistry
Volume289
Issue number21
DOIs
StatePublished - 2014

Fingerprint

Dive into the research topics of 'Mortalin/GRP75 binds to complement C9 and plays a role in resistance to complement-dependent cytotoxicity'. Together they form a unique fingerprint.

Cite this